387 related articles for article (PubMed ID: 19693090)
1. Receptor systems controlling natural killer cell function are genetically stratified in Europe.
Guinan KJ; Cunningham RT; Meenagh A; Dring MM; Middleton D; Gardiner CM
Genes Immun; 2010 Jan; 11(1):67-78. PubMed ID: 19693090
[TBL] [Abstract][Full Text] [Related]
2. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F
Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
[TBL] [Abstract][Full Text] [Related]
3. Different KIRs confer susceptibility and protection to adults with latent autoimmune diabetes in Latvian and Asian Indian populations.
Shastry A; Sedimbi SK; Rajalingam R; Rumba I; Kanungo A; Sanjeevi CB
Ann N Y Acad Sci; 2008 Dec; 1150():133-8. PubMed ID: 19120281
[TBL] [Abstract][Full Text] [Related]
4. Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay.
Tajik N; Shahsavar F; Nasiri M; Radjabzadeh MF
Int J Immunogenet; 2010 Jun; 37(3):159-68. PubMed ID: 20193031
[TBL] [Abstract][Full Text] [Related]
5. KIR ligands and prediction of relapse after unrelated donor hematopoietic cell transplantation for hematologic malignancy.
Hsu KC; Gooley T; Malkki M; Pinto-Agnello C; Dupont B; Bignon JD; Bornhäuser M; Christiansen F; Gratwohl A; Morishima Y; Oudshoorn M; Ringden O; van Rood JJ; Petersdorf E;
Biol Blood Marrow Transplant; 2006 Aug; 12(8):828-36. PubMed ID: 16864053
[TBL] [Abstract][Full Text] [Related]
6. Hematopoietic stem cell transplantation: killer immunoglobulin-like receptor component.
Hsu KC; Pinto-Agnello C; Gooley T; Malkki M; Dupont B; Petersdorf EW
Tissue Antigens; 2007 Apr; 69 Suppl 1():42-5. PubMed ID: 17445161
[TBL] [Abstract][Full Text] [Related]
7. Associations between KIR epitope combinations expressed by HLA-B/-C haplotypes found in an HIV-1 infected study population may influence NK mediated immune responses.
Gaudieri S; Nolan D; McKinnon E; Witt CS; Mallal S; Christiansen FT
Mol Immunol; 2005 Feb; 42(4):557-60. PubMed ID: 15607813
[TBL] [Abstract][Full Text] [Related]
8. [Receptor-ligand analysis of killer cell Ig-like receptor in Jiangsu Han population].
Jiang LX; Xu LH; Qi CP; Wang YF
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Aug; 28(8):863-5. PubMed ID: 22863597
[TBL] [Abstract][Full Text] [Related]
9. KIR2DS3 is associated with protection against acute myeloid leukemia.
Shahsavar F; Tajik N; Entezami KZ; Fallah Radjabzadeh M; Asadifar B; Alimoghaddam K; Ostadali Dahaghi M; Jalali A; Ghashghaie A; Ghavamzadeh A
Iran J Immunol; 2010 Mar; 7(1):8-17. PubMed ID: 20371915
[TBL] [Abstract][Full Text] [Related]
10. Killer cell immunoglobulin-like receptors influence the innate and adaptive immune responses.
Rajalingam R
Iran J Immunol; 2007 Jun; 4(2):61-78. PubMed ID: 17652846
[TBL] [Abstract][Full Text] [Related]
11. KIR3DL1+HLA-B Bw4Ile80 and KIR2DS1+HLA-C2 combinations are both associated with ankylosing spondylitis in the Iranian population.
Tajik N; Shahsavar F; Poormoghim H; Radjabzadeh MF; Mousavi T; Jalali A
Int J Immunogenet; 2011 Oct; 38(5):403-9. PubMed ID: 21797986
[TBL] [Abstract][Full Text] [Related]
12. Killer immunoglobulin-like receptors (KIRs) and HLA-C allorecognition patterns implicative of dominant activation of natural killer cells contribute to recurrent miscarriages.
Faridi RM; Agrawal S
Hum Reprod; 2011 Feb; 26(2):491-7. PubMed ID: 21159685
[TBL] [Abstract][Full Text] [Related]
13. KIR2DS1-mediated activation overrides NKG2A-mediated inhibition in HLA-C C2-negative individuals.
Foley B; De Santis D; Lathbury L; Christiansen F; Witt C
Int Immunol; 2008 Apr; 20(4):555-63. PubMed ID: 18308713
[TBL] [Abstract][Full Text] [Related]
14. Killer Ig-like receptor ligand mismatch directs NK cell expansion in vitro.
Rose MJ; Brooks AG; Stewart LA; Nguyen TH; Schwarer AP
J Immunol; 2009 Oct; 183(7):4502-8. PubMed ID: 19748981
[TBL] [Abstract][Full Text] [Related]
15. Exploring the Role of Killer Cell Immunoglobulin-Like Receptors and Their HLA Class I Ligands in Autoimmune Hepatitis.
Littera R; Chessa L; Onali S; Figorilli F; Lai S; Secci L; La Nasa G; Caocci G; Arras M; Melis M; Cappellini S; Balestrieri C; Serra G; Conti M; Zolfino T; Casale M; Casu S; Pasetto MC; Barca L; Salustro C; Matta L; Scioscia R; Zamboni F; Faa G; Orrù S; Carcassi C
PLoS One; 2016; 11(1):e0146086. PubMed ID: 26744892
[TBL] [Abstract][Full Text] [Related]
16. Survival of AML patients receiving HLA-matched sibling donor allogeneic bone marrow transplantation correlates with HLA-Cw ligand groups for killer immunoglobulin-like receptors.
Sobecks RM; Ball EJ; Maciejewski JP; Rybicki LA; Brown S; Kalaycio M; Pohlman B; Andresen S; Theil KS; Dean R; Bolwell BJ
Bone Marrow Transplant; 2007 Apr; 39(7):417-24. PubMed ID: 17310134
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.
Gao X; Jiao Y; Wang L; Liu X; Sun W; Cui B; Chen Z; Zhao Y
Clin Immunol; 2010 Oct; 137(1):139-46. PubMed ID: 20643584
[TBL] [Abstract][Full Text] [Related]
18. Study of KIR expression and HLA ligands in CD56+ lymphocytes of drug resistant tuberculosis patients.
Mousavi T; Shahsavar F; Farnia P; Tajik N; Soofi M
Iran J Allergy Asthma Immunol; 2011 Sep; 10(3):189-94. PubMed ID: 21891825
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility to pulmonary tuberculosis in Iranian individuals is not affected by compound KIR/HLA genotype.
Tajik N; Shah-hosseini A; Mohammadi A; Jafari M; Nasiri M; Radjabzadeh MF; Farnia P; Jalali A
Tissue Antigens; 2012 Feb; 79(2):90-6. PubMed ID: 22128749
[TBL] [Abstract][Full Text] [Related]
20. Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis.
Lorentzen AR; Karlsen TH; Olsson M; Smestad C; Mero IL; Woldseth B; Sun JY; Senitzer D; Celius EG; Thorsby E; Spurkland A; Lie BA; Harbo HF
Ann Neurol; 2009 Jun; 65(6):658-66. PubMed ID: 19630074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
